University of Wisconsin–Madison

(TCAD) A Phase 2 multi-center, randomized, double blind, placebo controlled, parallel group study to evaluate the efficacy and safety of T-817MA in patients with mild to moderate Alzheimer’s Disease

August 2014 to April 2016

This project led by: Sanjay Asthana, MD